Keros Therapeutics (KROS) Treasury Stock (2025 - 2026)
Keros Therapeutics' Treasury Shares came in at $384.56 million for Q2 2026.
Powered by 
Analysis
Keros Therapeutics (KROS) Treasury Stock (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Stock (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -3.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 76.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.62 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 64.59 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 115.20 Bn |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 386.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 386.21 Mn |
| Jun 30, 2026 | 384.56 Mn |
| Mar 31, 2026 | 384.56 Mn |
| Dec 31, 2025 | 384.56 Mn |
API Access
Keros Therapeutics Treasury Stock API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();